Food and Drug Administration Drug Safety Podcast
FDA Drug Safety Podcast: FDA warns about increased risk of serious pancreatitis with irritable bowel drug Viberzi (eluxadoline) in patients without a gallbladder
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:00:00
- More information
Informações:
Synopsis
FDA Drug Safety Podcast: FDA warns that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder.
